Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$36,085,930
+$8,677,841 QoQ
Shares Held
143,403
+13.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#437
of 4,153 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CSM Advisors, LLC holds $167,508,675 across 11 Drug Manufacturers - General names. ABBV ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
219,688 | $55,794,161 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
143,403 | $36,085,930 | |
| 3 | LLY |
ELI LILLY & Co
|
27,478 | $32,957,940 | |
| 4 | PFE |
Pfizer Inc
|
889,436 | $21,417,618 | |
| 5 | SNY |
Sanofi
|
360,443 | $15,376,498 | |
| 6 | NVS |
Novartis AG
|
11,160 | $1,748,995 | |
| 7 | MRK |
Merck & Co., Inc.
|
10,162 | $1,305,817 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
9,282 | $1,172,687 |
All Filings in ABBV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,085,930 | 143,403 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $27,408,089 | 126,020 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,728,558 | 108,226 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $23,116,490 | 99,838 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,943,328 | 96,667 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||